TipRanks on MSN

Aldeyra Therapeutics completes promising phase 2 trial for alcohol-associated hepatitis

Aldeyra Therapeutics ($ALDX) announced an update on their ongoing clinical study. Study Overview: Aldeyra Therapeutics recently completed a Phase ...